👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

Palantir lands $99.6 million deal with U.S. State Department

Published 03/08/2023, 06:26 AM
Updated 03/08/2023, 06:31 AM
© Reuters. FILE PHOTO: The logo of U.S. software company Palantir Technologies is seen in Davos, Switzerland, May 22, 2022. Picture taken May 22, 2022.   REUTERS/Arnd Wiegmann/File Photo
PLTR
-

By Jeffrey Dastin

(Reuters) - Palantir Technologies (NYSE:PLTR) Inc has won a contract to sell up to $99.6 million worth of software to the U.S. Department of State for monitoring the health of the diplomatic corps, the company told Reuters ahead of a Wednesday announcement.

The U.S. data analytics firm said the project - Axiom - would help the Bureau of Medical Services respond faster to any health crises faced by the embassy staff and their families.

The bureau has sought software to record health incidents, predict risks, manage medical-evacuation missions and handle other tasks, according to a government document.

The news reflects how Palantir is aiming to secure government deals beyond the military and intelligence work central to its business, even as analysts have said such opportunities are being delayed by the U.S. budget scrutiny.

Last month, Palantir reported its first profitable quarter, during which sales grew faster on government business rather than revenue from the private sector partly due to economic uncertainty.

© Reuters. FILE PHOTO: The logo of U.S. software company Palantir Technologies is seen in Davos, Switzerland, May 22, 2022. Picture taken May 22, 2022.   REUTERS/Arnd Wiegmann/File Photo

Palantir told Reuters the State Department has already paid the company $10 million as part of the purchase agreement, and it will book the remaining value over the next five years.

The Denver, Colorado-headquartered company said the deal continues a pilot dating back to 2021 and other State Department work since 2017.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.